π― 320+/360 Revision Pack β Human Reproduction + Reproductive Health
π
Built: 2026-07-20
Target: 320+/360 Biology
One combined revision weapon for both Class 12 chapters β Ch 2 (Human Reproduction) and Ch 3 (Reproductive Health). π₯ flags highest-yield facts that NEET repeats every year. All hormones, cycle-day counts, chromosome ploidies, gestation figures and full-forms are exact.
1 One-liner Facts & Exceptions MCQ-ready
- π₯Humans are viviparous, undergo internal fertilisation and show gametic (diploid) sexuality.
- Human reproductive events are cyclic; menstrual cycle begins at puberty (menarche), ends at menopause.
- Testes lie outside the abdominal cavity in the scrotum β maintains ~ 2β2.5 Β°C lower than body temp (needed for spermatogenesis).
- Each testis has ~ 250 compartments (testicular lobules); each has 1β3 seminiferous tubules.
- Seminiferous tubules are lined by spermatogonia (germ cells) & Sertoli cells (nurse cells, provide nutrition, secrete inhibin).
- Leydig cells (interstitial cells, between tubules) β secrete testosterone.
- Route of sperm: seminiferous tubule β rete testis β vasa efferentia β epididymis β vas deferens β ejaculatory duct β urethra β urethral meatus.
- Male accessory glands: 1 pair seminal vesicles, 1 prostate gland, 1 pair bulbourethral (Cowper's) glands.
- Seminal plasma is rich in fructose, calcium and certain enzymes (energy for sperm).
- Semen = sperm + seminal plasma. 200β300 million sperm per ejaculation; β₯ 60 % must have normal morphology & motility for fertility.
- π₯Female reproductive parts: 1 pair ovaries, 1 pair oviducts (fallopian tubes), uterus, cervix, vagina, external genitalia.
- Ovary produces the ovum + several steroid hormones (oestrogen, progesterone).
- Oviduct = infundibulum (fimbriae) β ampulla β isthmus. Fertilisation occurs at the ampullaryβisthmic junction.
- Uterus = "womb"; wall has 3 layers: perimetrium, myometrium, endometrium. Endometrium sheds in menstruation.
- Mammary glands: paired; 15β20 mammary lobes per breast; alveoli β tubules β mammary duct β mammary ampulla β lactiferous duct.
- π₯Spermatogenesis: at puberty; occurs in seminiferous tubules; controlled by FSH & LH.
- Spermatogonia (2n, 46) β Primary spermatocyte (2n, 46) β Meiosis I β Secondary spermatocyte (n, 23) β Meiosis II β Spermatid (n, 23) β Spermiogenesis β Spermatozoa (n, 23).
- Sperm production takes ~64 days (~2 months) in humans.
- Sperm head has haploid nucleus + acrosome (contains hyaluronidase enzyme). Middle piece = mitochondria (energy).
- π₯Oogenesis begins in fetal life (~7 million oogonia by 5th month) β arrest at prophase-I of meiosis I β resume at puberty.
- At birth: ~1β2 million primary oocytes per ovary. At puberty: ~ 60 000β80 000. Only ~450 ovulate in a woman's lifetime.
- Primary oocyte β Meiosis I (unequal) β Secondary oocyte (n) + 1st polar body. Meiosis I completes just before ovulation.
- Secondary oocyte begins Meiosis II but arrests at metaphase-II β completes only if fertilised.
- Secondary oocyte + sperm β completion of Meiosis II β ovum + 2nd polar body.
- Follicle stages: primordial β primary β secondary β tertiary β Graafian follicle β ovulation β corpus luteum.
- Graafian follicle has an antrum (fluid-filled cavity), zona pellucida around the oocyte.
- π₯Menstrual cycle length β 28 days; ovulation on day 14 (mid-cycle).
- Phases: menstrual (1β5) β follicular/proliferative (6β13) β ovulatory (~day 14, LH surge) β luteal/secretory (15β28).
- LH surge causes ovulation; corpus luteum secretes progesterone to maintain endometrium.
- If no fertilisation: corpus luteum degenerates β progesterone falls β endometrium breaks down β menstruation begins.
- Menstruation is a definitive sign of a non-pregnant, healthy female.
- Menstrual cycle first begins at puberty = menarche; permanent cessation at ~ 45β50 = menopause.
- π₯Fertilisation site: ampulla of the oviduct. Only one sperm fuses with the ovum (block by cortical granules).
- Fertilisation restores diploidy (2n = 46); baby's sex decided by father (X or Y sperm).
- Zygote β 2-cell β 4-cell β 8-cell β 16-cell (morula) β blastocyst (has trophoblast + inner cell mass, forms during cleavage while moving down oviduct).
- Cleavage occurs while embryo moves down the fallopian tube toward the uterus.
- π₯Implantation: blastocyst attaches to uterine wall (endometrium) β ~ day 7 after fertilisation.
- Placenta: temporary organ between developing embryo & maternal wall. Chorionic villi + uterine tissue = interdigitating fingers.
- Placenta functions: gas & nutrient exchange, waste removal, hormone production. Secretes hCG, hPL, oestrogen, progestogens, relaxin (in later stages).
- Human gestation period = ~ 9 months (280 days β 40 weeks).
- Fetal heart forms in 1st month; limbs & digits by 2nd month; most organs formed by 12 weeks (end of 1st trimester).
- Fetal hair on head + eyelids formed by 5th month. By 24 weeks (6th month): body covered by fine hair (lanugo).
- By end of 9th month β fetus is fully developed & ready for delivery.
- Parturition triggered by fetal ejection reflex β signals from fully developed fetus + placenta β oxytocin from maternal pituitary β uterine contractions ("labor").
- Milk production (lactation) triggered by prolactin; milk ejection triggered by oxytocin.
- First few days' milk = colostrum: contains IgA antibodies, critical for newborn immunity.
- π₯hCG (human chorionic gonadotropin) β detected in urine β basis of pregnancy tests.
- India's 1st RCH programme launched by Govt. of India in 1951 (family planning was one of the first initiatives).
- Sex ratio at birth in India β legal action against sex-selective abortion via Amniocentesis (mis)use; banned by law.
- NEET-testable STDs (Sexually Transmitted Infections): Gonorrhoea, Syphilis, Chlamydiasis, Genital herpes, Genital warts, Trichomoniasis, Hepatitis-B, HIV/AIDS.
- Hepatitis B, Genital herpes and HIV/AIDS are the STDs that are NOT completely curable.
- STDs are most common in age group 15β24 years.
- π₯Ideal contraceptive: user-friendly, easily available, effective, reversible, with fewer side-effects, no interference with sexual drive.
- Contraceptives are grouped into: Natural, Barrier, IUDs, Oral pills, Injectables, Implants, Surgical (sterilisation).
- Lactational amenorrhoea: absence of menstruation during intense lactation (up to 6 months post-partum); natural birth control.
- Natural methods: Rhythm/periodic abstinence, Withdrawal (coitus interruptus), Lactational amenorrhoea.
- Barrier methods: Condoms (male & female), Diaphragms, Cervical caps, Vaults. Also prevent STDs (condoms).
- Saheli = oral contraceptive pill developed by CDRI, Lucknow. Non-steroidal. Once a week.
- India's most-common condom brands (referenced in NCERT): Nirodh.
- π₯IUDs β non-medicated: Lippes loop. Copper-releasing: CuT, Cu-7, Multiload-375. Hormone-releasing: Progestasert, LNG-20.
- Copper ions in Cu-IUDs suppress sperm motility & fertilising capacity.
- Hormonal IUDs make uterus unsuitable for implantation and cervix hostile to sperm.
- Surgical sterilisation: Vasectomy (male, cut/tie vas deferens) & Tubectomy (female, cut/tie fallopian tube).
- π₯MTP (Medical Termination of Pregnancy) β safe up to 12 weeks; second trimester termination is much riskier. Legalised in India in 1971.
- MTP legal to prevent forced pregnancies (rape/incest), when fetus has serious abnormalities, or when pregnancy is dangerous to mother.
- Amniocentesis was originally to detect genetic disorders (Down, chromosomal abnormalities, sex-linked disorders); banned for sex determination in India.
- π₯ART (Assisted Reproductive Technology) methods for infertile couples: IVF, ZIFT, GIFT, ICSI, AI (IUI), ET.
2 Hormones Table Very high-yield
| Hormone | Source | Target | Function | Peaks / acts |
| GnRH | Hypothalamus | Anterior pituitary | Triggers FSH & LH release | Puberty onwards, pulsatile |
| FSH | Anterior pituitary | β Sertoli cells Β· β ovarian follicles | β initiates spermatogenesis (nutrition via Sertoli) Β· β follicle growth & oestrogen synthesis | Rises in early follicular phase |
| LH | Anterior pituitary | β Leydig cells Β· β theca cells + follicle | β testosterone release Β· β mid-cycle LH surge β ovulation; forms corpus luteum | Day 14 surge (ovulation) |
| Testosterone | Leydig (interstitial) cells | All male reproductive parts | Male secondary sex characters, spermatogenesis, muscle mass | From puberty |
| Inhibin | Sertoli cells (β) / granulosa (β) | Anterior pituitary | Feedback inhibition of FSH | Continuously in reproductive years |
| Oestrogen | Ovarian follicle (granulosa) | Female repro system, breast, bones | Female 2Β° sex characters, follicle growth, endometrial proliferation | Peaks just before ovulation (day 13) |
| Progesterone | Corpus luteum (also placenta later) | Endometrium, mammary gland | Maintains endometrium, prepares for implantation, prevents new ovulation | Peaks in luteal phase (day 21) |
| hCG | Trophoblast of embryo β placenta | Corpus luteum | Maintains corpus luteum β keeps progesterone high in early pregnancy Β· basis of pregnancy test | Peaks around 8β10 weeks |
| hPL (human placental lactogen) | Placenta | Maternal metabolism, mammary gland | Prepares mammary glands, alters maternal glucose metabolism | Late pregnancy |
| Relaxin | Corpus luteum & placenta | Pelvic ligaments, cervix | Relaxes cervix & pelvic ligaments before delivery | End of pregnancy |
| Oxytocin | Posterior pituitary | Uterine smooth muscle Β· mammary duct | Uterine contractions during labor Β· milk ejection reflex | Parturition & suckling |
| Prolactin | Anterior pituitary | Mammary gland (alveoli) | Milk synthesis (lactogenesis) | Late pregnancy & lactation |
3 Sequences & Cycles (arrow flowcharts) Order-questions
Spermatogenesis
Spermatogonium (2n=46) β grows β Primary spermatocyte (2n=46) β Meiosis I β 2 Secondary spermatocytes (n=23) β Meiosis II β 4 Spermatids (n=23) β Spermiogenesis β 4 Spermatozoa (n=23) β Spermiation (release into tubule lumen)
Oogenesis
Oogonium (2n) [fetal] β Primary oocyte (2n, arrested at prophase-I) [until puberty] β resumes β Meiosis I β Secondary oocyte (n) + 1st polar body β begins Meiosis II β arrests at metaphase-II β ovulated β fertilised by sperm β completes Meiosis II β Ovum (n) + 2nd polar body
Menstrual cycle (~28 days)
Days 1β5 Menstrual phase (shedding) β Days 6β13 Follicular/Proliferative (FSH β β follicle grows β oestrogen β β endometrium rebuilds) β Day 14 Ovulation (LH surge β Graafian follicle ruptures) β Days 15β28 Luteal/Secretory (corpus luteum β progesterone β β endometrium ready) β no fertilisation β CL degenerates β back to Day 1
Follicle progression
Primordial follicle β Primary β Secondary β Tertiary (antrum forms) β Graafian (mature) β Ovulation β Corpus luteum β (if no pregnancy) Corpus albicans
Fertilisation β implantation
Sperm enters ampulla β acrosome reaction β zona pellucida crossed β sperm fuses with 2Β° oocyte β Meiosis II completes β zygote (2n) β cleavage: 2β4β8β16-cell (morula) β blastocyst (trophoblast + inner cell mass) β enters uterus (~day 4-5) β implantation on endometrium (~day 7)
Embryonic milestones (gestation)
1 month: heart forms Β· 2 months: limbs & digits Β· 12 weeks (1st trimester): most organs formed, external genitalia Β· 5 months: first movements + head hair Β· 24 weeks (6 mo): lanugo + eyelids differentiate Β· 9 months: full-term, ready for delivery
Parturition & lactation
Full-term fetus + placenta β fetal ejection reflex β maternal oxytocin release β uterine contractions β cervix dilates β baby born β placenta expelled Β· Prolactin β milk synthesis Β· Oxytocin β milk ejection Β· Early milk = colostrum (rich in IgA antibodies)
4 Diagrams to Master (label from blank)
Male reproductive system β testes, scrotum, epididymis, vas deferens, seminal vesicle, prostate, bulbourethral gland, urethra, penis, ureter, urinary bladder.
T.S. of testis β seminiferous tubule with spermatogonia at periphery β primary/secondary spermatocytes β spermatids β sperm heading to lumen; Sertoli cells; Leydig (interstitial) cells between tubules; tunica albuginea outside.
Sperm structure β head (nucleus + acrosome), neck, middle piece (mitochondria = "power house"), tail.
Female reproductive system β ovaries, fallopian tube (infundibulum with fimbriae, ampulla, isthmus), uterus (fundus, body, cervix), vagina, external genitalia (mons pubis, labia majora/minora, clitoris, hymen).
T.S. of ovary β germinal epithelium, tunica albuginea, stroma with primary follicle, secondary follicle, tertiary follicle, Graafian follicle (antrum + ovum + zona pellucida + granulosa cells), corpus luteum.
Ovum / secondary oocyte β plasma membrane, cytoplasm, nucleus, zona pellucida, corona radiata, 1st polar body.
Mammary gland (LS) β mammary lobes (15β20) β alveoli β tubules β mammary duct β mammary ampulla β lactiferous duct.
Menstrual cycle chart β 4 phases with hormone levels (FSH, LH, oestrogen, progesterone) and endometrial thickness plotted vs day.
Blastocyst β trophoblast (outer), inner cell mass (embryoblast), blastocoel (cavity).
Placenta & umbilical cord β chorionic villi interdigitating with uterine tissue; umbilical arteries (2) & umbilical vein (1).
5 Full-forms & Techniques RH exam magnet
| Abbrev. | Full form | What it does |
| FSH | Follicle-Stimulating Hormone | Stimulates gametogenesis in both sexes |
| LH | Luteinising Hormone | Ovulation (β) & testosterone release (β) |
| GnRH | Gonadotropin-Releasing Hormone | Hypothalamic trigger for FSH/LH |
| hCG | Human Chorionic Gonadotropin | Placental hormone; pregnancy test marker |
| hPL | Human Placental Lactogen | Placental hormone; prepares maternal metabolism |
| RCH | Reproductive and Child Health care | Govt of India programme (1951 onwards) |
| IUD / IUCD | Intra-Uterine (Contraceptive) Device | Placed in uterus; blocks implantation/sperm motility (Cu-T, LNG-20) |
| MTP | Medical Termination of Pregnancy | Induced abortion; safe up to 12 weeks (legalised 1971 in India) |
| STD / STI | Sexually Transmitted Disease / Infection | Gonorrhoea, syphilis, chlamydia, HIV, HBV, herpes, warts, trichomoniasis |
| ART | Assisted Reproductive Technology | Umbrella for IVF, ZIFT, GIFT, ICSI, AI, ET |
| IVF | In-Vitro Fertilisation | Ovum + sperm fused in lab β embryo β uterus. "Test-tube baby" |
| ET | Embryo Transfer | Embryo transferred to uterus (or fallopian tube for early-stage) |
| ZIFT | Zygote Intra-Fallopian Transfer | Zygote/early embryo (β€ 8-cell) transferred to fallopian tube |
| IUT | Intra-Uterine Transfer | Embryo > 8-cell transferred into uterus |
| GIFT | Gamete Intra-Fallopian Transfer | Ovum from donor transferred into fallopian tube of female who cannot produce ova but can support |
| ICSI | Intra-Cytoplasmic Sperm Injection | One sperm directly injected into ovum; helps low sperm count/motility cases |
| AI / IUI | Artificial Insemination / Intra-Uterine Insemination | Semen introduced into female tract (vagina or uterus) |
| AIDS | Acquired Immuno-Deficiency Syndrome | Caused by HIV; sexually transmitted |
| HIV | Human Immunodeficiency Virus | Retrovirus; targets helper T-cells |
| HBV | Hepatitis-B Virus | Blood/sexual transmission; not fully curable |
Contraceptives grouped by type
| Group | Methods (NCERT) |
| Natural / Behavioural | Periodic abstinence (rhythm), Withdrawal (coitus interruptus), Lactational amenorrhoea |
| Barrier | Condoms (male, female β Nirodh), Diaphragms, Cervical caps, Vaults (reusable) |
| IUDs | Non-medicated: Lippes loop Β· Cu-releasing: CuT, Cu-7, Multiload-375 Β· Hormonal: Progestasert, LNG-20 |
| Oral / Hormonal pills | Combined pills (oestrogen+progestogen); Progestogen-only pills; Saheli (non-steroidal, once-a-week, CDRI Lucknow) |
| Injectables / Implants | Progestogen or progestogen+oestrogen combinations under skin or IM |
| Surgical (Sterilisation) | Vasectomy (β vas deferens cut/tied) Β· Tubectomy (β fallopian tube cut/tied) |
| Emergency | Progestogen or IUD within 72 hrs of coitus / rape |
6 Numbers & Data Sheet
| Item | Value |
| Testicular temp | ~ 2β2.5 Β°C lower than body |
| Testicular lobules / testis | ~ 250 |
| Seminiferous tubules per lobule | 1β3 |
| Chromosomes: spermatogonium / 1Β° / 2Β° / spermatid / sperm | 2n=46 / 2n=46 / n=23 / n=23 / n=23 |
| Ploidy transition | 2n β n at end of Meiosis I |
| Duration of spermatogenesis | ~ 64 days |
| Sperm per ejaculation | 200β300 million (β₯60 % normal for fertility) |
| Ova (oogonia) at 5 months of fetal life | ~ 7 million |
| Primary oocytes at birth | ~ 1β2 million per ovary |
| Follicles at puberty | ~ 60 000β80 000 |
| Ova ovulated in a woman's life | ~ 450 |
| Menstrual cycle length | ~ 28 days |
| Ovulation day | Day 14 (approx) |
| Menarche | Onset of first menstruation (puberty) |
| Menopause | ~ 45β50 years |
| Fertilisation site | Ampulla of oviduct |
| Implantation day | ~ Day 7 after fertilisation |
| Gestation period | ~ 9 months (280 days β 40 weeks) |
| Mammary lobes per breast | 15β20 |
| MTP legalised in India | 1971; safe up to 12 weeks |
| STDs most common age-group | 15β24 years |
| ZIFT vs IUT cell-stage cutoff | β€ 8-cell = ZIFT ; > 8-cell = IUT |
7 Examples Bank
| Category | NCERT examples |
| Bacterial STDs | Gonorrhoea, Syphilis, Chlamydiasis |
| Viral STDs | Genital herpes, Genital warts, HIV/AIDS, Hepatitis-B |
| Protozoan STD | Trichomoniasis |
| STDs not fully curable | Hepatitis-B, Genital herpes, HIV/AIDS |
| Barrier contraceptives | Nirodh, female condom, diaphragm, cervical cap, vault |
| Cu-releasing IUDs | CuT, Cu-7, Multiload-375 |
| Hormonal IUDs | Progestasert, LNG-20 |
| Non-steroidal oral pill | Saheli (CDRI Lucknow) |
| Surgical sterilisation | Vasectomy (β) Β· Tubectomy (β) |
| ART techniques | IVF-ET, ZIFT, IUT, GIFT, ICSI, AI/IUI |
| Assisted diagnostic tools | Amniocentesis (for genetic disorders; banned for sex-determination) |
8 Trap Words / Confusable Pairs
FSH (follicle stimulation) vs LH (ovulation trigger) β both from anterior pituitary.
Oestrogen (follicular, from follicle) vs Progesterone (luteal, from CL).
Meiosis I β completes just before ovulation. Meiosis II β completes only after fertilisation.
Menstrual phase (days 1β5) vs Menopause (permanent cessation).
Spermatogenesis (from puberty) vs Oogenesis (begins in fetal life).
Sertoli cells (nurse, inhibin) vs Leydig cells (interstitial, testosterone).
Ampulla (fertilisation) vs Isthmus (narrow, connects to uterus).
hCG (from embryo/placenta, pregnancy test) vs hPL (placenta, maternal metabolism).
ZIFT (β€ 8-cell, into fallopian tube) vs IUT (> 8-cell, into uterus).
GIFT (donor ovum β fallopian tube) vs IUI (semen β uterus).
ICSI (sperm injected into ovum) vs IVF (sperm + ovum fused in dish).
Vasectomy (β, vas deferens) vs Tubectomy (β, fallopian tube).
Copper IUDs (block sperm motility) vs Hormonal IUDs (endometrium unfit).
Prolactin (milk synthesis) vs Oxytocin (milk ejection + parturition).
Colostrum (first-few-days milk, IgA-rich) vs Mature milk.
Corpus luteum (yellow body, progesterone) vs Corpus albicans (degenerated scar).
9 Mnemonics
Sperm route β "SEEE-Vaas Erna Urethra": Seminiferous tubule β rEte testis β Efferent ducts β Epididymis β Vas deferens β Ejaculatory duct β Urethra.
Menstrual phases β "MFOL": Menstrual (1β5) Β· Follicular (6β13) Β· Ovulatory (14) Β· Luteal (15β28).
Ovulation hormone sequence β "GFOL-Pro": GnRH β FSH β Oestrogen β LH surge β Progesterone (via CL).
ART menu β "I ZIP GAI": IVF Β· ZIFT Β· IUT Β· Progestasert (IUD) Β· GIFT Β· AI Β· ICSI. (Just remember all 6 names.)
STDs (bacterial vs viral) β "BAC = GSC" (Gonorrhoea, Syphilis, Chlamydiasis) β bacterial. Rest = viral/protozoan.
Non-curable STDs β "H-H-H": Hepatitis-B Β· Herpes (genital) Β· HIV/AIDS.
Contraceptive groups β "N-B-I-O-S": Natural Β· Barrier Β· IUD Β· Oral/hormonal Β· Surgical.
Oogonia count-down β "7 M β 1β2 M β 60β80 K β 450" (fetal 5 mo β birth β puberty β total ovulated in life).
Cleavage counts β "2, 4, 8, 16 = morula; hollow ball = blastocyst". 16-cell is memorised as morula-endpoint.
Placental hormones β "hCG Β· hPL Β· Oestrogen Β· Progestogens Β· Relaxin" (5 hormones β first two are placenta-only, others are shared).
10 Cross-chapter Connections
- Chemical Coordination & Integration β pituitary axis (GnRH β FSH/LH), placenta as endocrine organ.
- Human Health & Disease β HIV/AIDS, Hepatitis-B are shared with immunity/STDs chapter.
- Genetics β pedigree of X-linked disorders, chromosomal disorders detected via amniocentesis.
- Molecular basis of inheritance β meiosis in gametogenesis; segregation of alleles.
- Biotechnology & its applications β ART techniques link to recombinant DNA (test-tube baby technology).
- Evolution β internal fertilisation & placentation as mammalian adaptation.
11 High-Yield Top 15 Master these first
- Fertilisation site = ampulla of oviduct. Only one sperm fuses.
- Meiosis I completes just before ovulation; Meiosis II completes only after fertilisation.
- Menstrual cycle: 28 days; ovulation on day 14 due to LH surge.
- Sertoli = nurse cells (inhibin); Leydig = interstitial (testosterone).
- Sperm per ejaculation = 200β300 million; β₯ 60 % normal for fertility.
- Oogonia count-down: 7 M fetal β 1β2 M birth β 60β80 K puberty β 450 ovulated.
- Cleavage sequence: zygote β 2 β 4 β 8 β 16-cell (morula) β blastocyst β implantation ~ day 7.
- hCG = pregnancy test marker (secreted by trophoblast/placenta).
- Placental hormones: hCG, hPL, oestrogen, progesterone, relaxin.
- Parturition: fetal ejection reflex β oxytocin β uterine contractions.
- Prolactin = milk synthesis; Oxytocin = milk ejection. First milk = colostrum (IgA).
- Cu-IUDs (CuT, Cu-7, Multiload-375) β reduce sperm motility. Hormonal IUDs β Progestasert, LNG-20.
- Saheli = non-steroidal, once-a-week oral pill from CDRI Lucknow.
- MTP safe up to 12 weeks, legalised in India in 1971.
- ART menu: IVF-ET Β· ZIFT (β€8-cell β fallopian) Β· IUT (>8-cell β uterus) Β· GIFT (donor ovum) Β· ICSI (sperm into ovum) Β· AI/IUI.
12 Self-Test β 15 MCQs
Q1. Fertilisation in humans occurs in:
(a) Ovary (b) Uterus (c) Ampulla of oviduct (d) Cervix
Answer
(c) Ampulla β the widest part of the fallopian tube, near the ovary.
Q2. Which hormone causes ovulation?
(a) FSH (b) LH surge (c) Progesterone (d) Oestrogen
Answer
(b) LH surge at ~ day 14 triggers Graafian follicle rupture.
Q3. Sertoli cells secrete:
(a) Testosterone (b) Progesterone (c) Inhibin (d) FSH
Answer
(c) Inhibin β feedback inhibitor of FSH. Testosterone is from Leydig.
Q4. The hormone detected in a urine-based pregnancy test is:
(a) hPL (b) hCG (c) LH (d) Progesterone
Answer
(b) hCG β secreted by trophoblast/placenta.
Q5. Correct sequence of embryonic development:
(a) Zygote β morula β blastocyst β implantation
(b) Zygote β blastocyst β morula β implantation
(c) Zygote β morula β implantation β blastocyst
(d) Zygote β blastocyst β implantation β morula
Answer
(a) Zygote β cleavage β morula (16-cell) β blastocyst β implantation on endometrium (~day 7).
Q6. Meiosis II of oocyte is completed:
(a) Before ovulation (b) Just before puberty (c) Only after fertilisation (d) During cleavage
Answer
(c) Only after fertilisation β 2Β° oocyte is arrested at metaphase-II until sperm fuses.
Q7. Which is NOT an ART technique?
(a) IVF (b) ZIFT (c) MTP (d) GIFT
Answer
(c) MTP β that's Medical Termination of Pregnancy, not an ART.
Q8. Saheli is:
(a) Copper IUD (b) Non-steroidal oral contraceptive (c) Barrier method (d) Injectable
Answer
(b) Non-steroidal oral contraceptive from CDRI Lucknow, once a week.
Q9. Milk ejection is triggered by:
(a) Prolactin (b) Oestrogen (c) Oxytocin (d) hCG
Answer
(c) Oxytocin β from posterior pituitary; prolactin synthesises milk, oxytocin ejects it.
Q10. Implantation of the blastocyst occurs around:
(a) Day 3 (b) Day 7 (c) Day 14 (d) Day 28
Answer
(b) Day 7 after fertilisation.
Q11. Which STD is NOT completely curable?
(a) Gonorrhoea (b) Syphilis (c) Chlamydiasis (d) HIV/AIDS
Answer
(d) HIV/AIDS β along with Hepatitis-B and Genital herpes. Bacterial ones (a, b, c) are curable.
Q12. Number of ova ovulated by a woman in her lifetime is approximately:
(a) 45 (b) 450 (c) 4500 (d) 45 000
Answer
(b) ~ 450 β from ~ 60 000β80 000 follicles present at puberty.
Q13. Which of the following is a Cu-releasing IUD?
(a) Lippes loop (b) Multiload-375 (c) Progestasert (d) LNG-20
Answer
(b) Multiload-375 (also CuT, Cu-7 are Cu-releasing). Lippes = non-medicated. Progestasert / LNG-20 = hormonal.
Q14. MTP is safest during:
(a) First 12 weeks (b) 13β24 weeks (c) After 24 weeks (d) Any time
Answer
(a) First 12 weeks β safe termination as per Indian law (1971).
Q15. Assertion: The corpus luteum secretes progesterone. Reason: Progesterone maintains the endometrium for possible implantation.
(a) Both true, R explains A (b) Both true, R doesn't explain A
(c) A true, R false (d) A false, R true
Answer
(a) Both true and connected β that's exactly why CL exists after ovulation.